22 related articles for article (PubMed ID: 37258396)
1. Promising Administrative Measures of Heart Failure and Future Directions.
Festa N; Wasfy JH; M V R Moura L
Circ Cardiovasc Qual Outcomes; 2023 Feb; 16(2):e009833. PubMed ID: 36688300
[No Abstract] [Full Text] [Related]
2. Opportunities for Care Optimization and Hospitalization Reduction for Older Persons With Heart Failure.
Azad N
Clin Med Insights Cardiol; 2019; 13():1179546819841597. PubMed ID: 31105431
[No Abstract] [Full Text] [Related]
3. Carfilzomib-induced thrombotic microangiopathy (TMA): an under-recognised spectrum of disease from microangiopathic haemolysis to subclinical TMA.
Ponraj R; Bryant A; Dunlop L; Range H; Cobrador C; Ling S; Hsu D
Blood Cancer J; 2023 Jul; 13(1):113. PubMed ID: 37495597
[No Abstract] [Full Text] [Related]
4. Whole-Exome sequencing analysis identified TMSB10/TRABD2A locus to be associated with carfilzomib-related cardiotoxicity among patients with multiple myeloma.
Tantawy M; Yang G; Algubelli RR; DeAvila G; Rubinstein SM; Cornell RF; Fradley MG; Siegel EM; Hampton OA; Silva AS; Lenihan D; Shain KH; Baz RC; Gong Y
Front Cardiovasc Med; 2023; 10():1181806. PubMed ID: 37408649
[TBL] [Abstract][Full Text] [Related]
5. Nutritional optimization in medical and surgical treatment of IBD patients.
Viganò C; Sampietro GM
Dig Liver Dis; 2023 Aug; 55(8):1026-1027. PubMed ID: 37355396
[No Abstract] [Full Text] [Related]
6. Nutritional care at centres managing patients with inflammatory bowel disease: A nationwide survey in Italy.
Saibeni S; Zanetti M; Bezzio C; Pironi L; Armuzzi A; Riso S; Caprioli F; Lezo A; Macaluso FS; Pugliese D; Daperno M; Giorgetti GM;
Dig Liver Dis; 2023 Aug; 55(8):1028-1033. PubMed ID: 37355395
[TBL] [Abstract][Full Text] [Related]
7. Response adaptive salvage with KTd and ASCT for functional high-risk multiple myeloma-The Australasian Leukemia and Lymphoma Group (ALLG) MM17 Trial.
Turner R; Quach H; Horvath N; Kerridge I; Lee E; Morris E; Kalff A; Khong T; Reynolds J; Spencer A
Br J Haematol; 2023 Aug; 202(3):530-538. PubMed ID: 37332079
[TBL] [Abstract][Full Text] [Related]
8. Race, quality of care, and outcomes of elderly patients hospitalized with heart failure.
Rathore SS; Foody JM; Wang Y; Smith GL; Herrin J; Masoudi FA; Wolfe P; Havranek EP; Ordin DL; Krumholz HM
JAMA; 2003 May; 289(19):2517-24. PubMed ID: 12759323
[TBL] [Abstract][Full Text] [Related]
9. Heart Failure Among Patients with Multiple Myeloma Treated with Carfilzomib-Based Versus Non-Carfilzomib-Based Regimens in the United States by Race.
Li S; Suehs BT; Fu A; Sangaré L; Kim C; Gastanaga VM; Liu J; Yan H; Xu Y; Mikhael J
Clin Lymphoma Myeloma Leuk; 2023 Aug; 23(8):616-625. PubMed ID: 37258396
[TBL] [Abstract][Full Text] [Related]
10. Real-world experience of carfilzomib-associated cardiovascular adverse events: SEER-Medicare data set analysis.
Bishnoi R; Xie Z; Shah C; Bian J; Murthy HS; Wingard JR; Farhadfar N
Cancer Med; 2021 Jan; 10(1):70-78. PubMed ID: 33169938
[TBL] [Abstract][Full Text] [Related]
11. Measuring cardiopulmonary complications of carfilzomib treatment and associated risk factors using the SEER-Medicare database.
Fakhri B; Fiala MA; Shah N; Vij R; Wildes TM
Cancer; 2020 Feb; 126(4):808-813. PubMed ID: 31721140
[TBL] [Abstract][Full Text] [Related]
12. Association of Racial and Socioeconomic Disparities With Outcomes Among Patients Hospitalized With Acute Myocardial Infarction, Heart Failure, and Pneumonia: An Analysis of Within- and Between-Hospital Variation.
Downing NS; Wang C; Gupta A; Wang Y; Nuti SV; Ross JS; Bernheim SM; Lin Z; Normand ST; Krumholz HM
JAMA Netw Open; 2018 Sep; 1(5):e182044. PubMed ID: 30646146
[TBL] [Abstract][Full Text] [Related]
13. Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (A.R.R.O.W.): interim analysis results of a randomised, phase 3 study.
Moreau P; Mateos MV; Berenson JR; Weisel K; Lazzaro A; Song K; Dimopoulos MA; Huang M; Zahlten-Kumeli A; Stewart AK
Lancet Oncol; 2018 Jul; 19(7):953-964. PubMed ID: 29866475
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
